$RYM

MAHONEY TIMOTHY sold $132K of RYM

MAHONEY TIMOTHY sold 5,000 shares of RYTHM, Inc. (RYM) at an average of $26.34 ($24.88–$28.00, $0.13M total) across 5 trades on 2026-06-11.

Original reporting
SEC EDGAR · MAHONEY TIMOTHY
Published Jun 15, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RYM
Neutral
low confidence
Mentioned
$RYM
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RYMNeutralLow
01

Why it matters

The newest fact is the director’s sale details (shares, price range, total value) and that there was no pre-arranged 10b5-1 plan stated.

02

Market read

Traders may monitor for additional insider activity, but the filing alone does not provide a new fundamental driver.

03

What to watch

The article does not state tax/option exercise context beyond an open-market sale, and it provides no follow-on company performance or guidance changes.

Relevance 4/10Novelty 5/10Timing: Filed 2026-06-15; sale executed 2026-06-11.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for RYTHM, Inc. (RYM).

Company-level read

Ticker impact

$RYMNeutralLow confidence
Context

SEC Form 4 shows director Timothy Mahoney sold $131,710 of RYM shares in an open-market sale across five trades on 2026-06-11.

Expected impact

Likely limited near-term impact; watch for follow-through only if additional filings show sustained selling or unusual patterns.

Evidence & confidence

The filing is a routine Form 4 open-market sale with no 10b5-1 plan and no accompanying company-specific news in the text.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Director selling can be driven by diversification or personal liquidity needs rather than negative expectations, especially when trades are spread across multiple prices.

Key entities

  • RYTHM, Inc.

    Company whose director insider sale is disclosed on SEC Form 4.

  • MAHONEY TIMOTHY

    Director who sold 5,000 shares of RYM on 2026-06-11.

Related articles

$RYMMed

RYTHM, Inc. (RYM): Results of Operations and Financial Condition

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea029949501ex99-1.htm PRESS RELEASE OF RYTHM, INC. DATED AUGUST 4, 2026 Exhibit 99.1 RYTHM, Inc. Reports Second Quarter 2026 Results ROLLING MEADOWS, IL, August 4, 2026 (GLOBE NEWSWIRE) – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose

$RYMMedAI 8/10

Daily NZX update, Friday, June 5, 2026

NZX 50 was up 0.3% at 3:00pm, though down 0.5% over five days and 2.6% over six months. Top gainers included Air New Zealand (+2%), Mainfreight (+2%) and Genesis Energy (+2%); biggest fallers were Kathmandu (-3%), A2 Milk (-2%) and Tourism Holdings (-2%). SmartShares ETFs were mixed. Meridian welcomed a draft Fast-track Panel decision on Lake Pūkaki access; Infratil completed a $200m capital bond offer; Ryman reported FY26 EBITDAF $88.3m and free cash flow $188.3m.

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.